10% Dextrose Injection 500ml

10% Glucose (10% Dextrose) Injection 500ml
  • Dosage: 10% Glucose
  • Volume:500ml per bottle / bag
  • Packaging: 500ml per bottle / bag*30/carton
  • Shelf Life: 36 months 

Click to add this item to cart.

Product Description

Product Name10% Glucose Injection / 10% Dextrose Injection
Specification10% w/v (10g dextrose per 100mL); 500mL total volume (50g dextrose per container)
Dosage FormSterile, Nonpyrogenic Large-Volume Parenteral Solution for Intravenous Infusion
Active IngredientDextrose (Glucose, anhydrous)
Pharmacological ClassParenteral Nutrient / Concentrated Caloric Source / Hypertonic Intravenous Fluid
Route of AdministrationIntravenous infusion only. For prolonged or continuous infusion, central venous access is recommended due to hypertonicity. NOT for intramuscular or subcutaneous injection.
Packaging500mL sterile plastic infusion container (PVC or non-PVC flexible bag) or glass bottle with rubber stopper and aluminum seal
StorageStore below 25°C, protected from light and excessive heat. Do not freeze. Keep container in overwrap until use (for plastic bags).
Shelf Life36 months (unopened)

Product Overview

10% Dextrose Injection (10% Glucose Injection) 500mL is a sterile, nonpyrogenic, hypertonic solution of dextrose (glucose) in Water for Injections, intended for intravenous infusion. Each 100mL of solution contains 10g of anhydrous dextrose (D-glucose), and each 500mL container delivers a total of 50g of dextrose. Dextrose is a monosaccharide and the primary physiological carbohydrate used by the body for energy production. 10% Dextrose Injection provides a more concentrated source of calories and carbohydrate than isotonic 5% dextrose solutions, and is used in situations requiring higher caloric intake in a smaller fluid volume, such as in the management of significant hypoglycemia, as a component of parenteral nutrition regimens, and for patients requiring fluid restriction but needing carbohydrate supplementation.

10% Dextrose Injection 500ml: What the Published Guidance Says

Crystalloid infusion solutions, energy substrates and parenteral nutrition components — the fluid-resuscitation and supportive-care layer underneath almost every inpatient protocol.

10% Dextrose Injection 500ml sits in the IV Fluids range. The notes below are the ones that most often change a specification, a label or a tender submission.

  • Presentation is part of the specification WHO's criterion for an essential medicine includes that it be available in appropriate dosage forms for the intended uses and patients. For infusion solutions that criterion is expressed as fill volume and container format — the difference between a 500 mL bottle and a 1 L bag is a formulary decision before it becomes a price decision. WHO — Essential medicines (fact sheet)
  • Electrolyte composition is what separates saline from balanced solutions The Model List publishes the electrolyte content of each crystalloid it carries: sodium chloride 0.9% at Na⁺ 154 mmol/L and Cl⁻ 154 mmol/L, the 5% + 0.9% glucose/sodium chloride combination at 150 mmol/L, and the 5% + 0.45% combination at 75 mmol/L. Comparing those figures against plasma composition is how a formulary committee decides which fluid to standardise on — and why lactated Ringer's, with a more physiological profile, is frequently the resuscitation default. WHO eEML — Glucose + sodium chloride
  • The Model List specifies the crystalloid formulations The 24th WHO Model List (2025) carries sodium chloride 0.9% isotonic (equivalent to Na⁺ 154 mmol/L and Cl⁻ 154 mmol/L) and glucose + sodium chloride combinations of 4% + 0.18%, 5% + 0.9% and 5% + 0.45%, classified under solutions correcting water, electrolyte and acid-base disturbances. Glucose + sodium chloride was first added in 1979. WHO eEML — Glucose + sodium chloride

These points are quoted because they shape how 10% Dextrose Injection 500ml is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

Ordering Parameters for 10% Dextrose Injection 500ml

Product Name10% Glucose Injection / 10% Dextrose Injection
Specification10% w/v (10g dextrose per 100mL); 500mL total volume (50g dextrose per container)
Dosage FormSterile, Nonpyrogenic Large-Volume Parenteral Solution for Intravenous Infusion
Active IngredientDextrose (Glucose, anhydrous)
Pharmacological ClassParenteral Nutrient / Concentrated Caloric Source / Hypertonic Intravenous Fluid
Route of AdministrationIntravenous infusion only. For prolonged or continuous infusion, central venous access is recommended due to hypertonicity. NOT for intramuscular or subcutaneous injection.
StorageStore below 25°C, protected from light and excessive heat. Do not freeze. Keep container in overwrap until use (for plastic bags).
Therapeutic groupIV Fluids — IV Fluids
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Human Albumin 20% 50ml, 20% Fat Emulsion Injection 100ml, Lactated Ringer’s Injection 500mL, 5% Dextrose Injection 500ml, Fructose Injection 5g/250mL.

Pharmacopoeial Standard, Release Testing & COA

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

10% Dextrose Injection 500ml is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The quality control package for the marketed pack covers:

  • Testing for dissolution or release profile (solid oral forms)
  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
  • Testing for microbial limits and preservative efficacy (multi-dose presentations)
  • Testing for heavy metals and elemental impurities

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packing, Labelling Languages & Export Paperwork

  • Pack size: 500mL sterile plastic infusion container (PVC or non-PVC flexible bag) or glass bottle with rubber stopper and aluminum seal. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, protected from light and excessive heat. Do not freeze. Keep container in overwrap until use (for plastic bags)..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
  • Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Marketing Authorisation & Tender Support

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
  • Batch manufacturing and packaging records released for inspection on request during supplier audits.
  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.

This page describes 10% Dextrose Injection 500ml as a product of the infusion solutions and parenteral nutrition named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

10% Dextrose Injection 500ml: Common Procurement Questions

What pack size is available for 10% Dextrose Injection 500ml?

The reference pack is 500mL sterile plastic infusion container (PVC or non-PVC flexible bag) or glass bottle with rubber stopper and aluminum seal. Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.

What documentation comes with a shipment of 10% Dextrose Injection 500ml?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.

Does the batch documentation for 10% Dextrose Injection 500ml support a registration filing?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

How should we compare fluid prices between suppliers?

On delivered cost per litre. Infusion solutions are bulky, so container format and fill volume change the freight component enough to reverse a unit-price comparison.

Which infusion solutions are on the WHO Model List?

Sodium chloride 0.9% isotonic, and glucose + sodium chloride in 4% + 0.18%, 5% + 0.9% and 5% + 0.45% combinations, under solutions correcting water, electrolyte and acid-base disturbances.

Products Commonly Ordered with 10% Dextrose Injection 500ml

Browse the full IV Fluids range; all Injectables; the complete product catalogue.

Request a Quotation for 10% Dextrose Injection 500ml

Send the specification, pack size, quantity and destination market for 10% Dextrose Injection 500ml 10g and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products